Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study
Johns Hopkins University
Stacie M Jones; Edwin H Kim; Kari C Nadeau; Anna Nowak-Wegrzyn; Robert A Wood; Hugh A Sampson; Amy M Scurlock; Sharon Chinthrajah; Julie Wang; Robert D Pesek; Sayantani B Sindher; Mike Kulis; Jacqueline Johnson; Katharine Spain; Denise C Babineau; Hyunsook Chin; Joy Laurienzo-Panza; Rachel Yan; David Larson; Tielin Qin; Don Whitehouse; Michelle L Sever; Srinath Sanda; Marshall Plaut; Lisa M Wheatley; A Wesley Burks; Immune Tolerance Network